Clinical Trial Update: A Study of JNS020QD in Patients With Chronic Pain [Phase 3]

View source ↗

Summary

Phase 3 trial of JNS020QD for chronic pain has completed; the snippet does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• JNS020QD

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED